The receptor for erythropoietin (Epo) belongs to the cytokine receptor family and lacks a tyrosine kinase domain. However, it has been hypothesized that a tyrosine kinase, JakZ, associates with the membrane proximal cytoplasmic region of Epo receptor (EpoR) and mediates the growth signaling from the receptor through tyrosine phosphorylation of cellular substrates. To explore the growth signaling pathways from the EpoR, we analyzed substrates of tyrosine phosphorylation induced by Epo stimulation in cells expressing various mutant EpoRs. The vav proto-oncogene product was found t o be tyrosine phosphorylated after Epo stimulation in cells expressing the wild-type EpoR or a truncated receptor, H mutant, that retains the growth signaling function. In these cells, Epo also induced the expression of a serinelthreonine kinase, Pim-l. However, Epo stimulation E RYTHROPOIETIN (Epo) is a hematopoietic growth factor that regulates the proliferation and differentiation of erythroid progenitor cells.'.' The receptor for Epo ( E~O R )~.~ belongs to the cytokine receptor superfamily, which includes receptors for most of the hematopoietic growth factor^.^.' The receptors of this superfamily are characterized by four conserved cysteine residues and a TrpSer-X-Trp-Ser (WSXWS) motif in the extracellular domain. Although the intracellular domain of the cytokine receptors lacks a tyrosine kinase domain, activation of these receptors induces tyrosine phosphorylation of cellular Using cell lines expressing various mutant EpoRs, we previously showed that a membrane proximal cytoplasmic region of the EpoR plays a crucial role in interaction with and activation of a tyrosine kinase, Jak2.9,'0 We also showed that the carboxyl-terminal region of 108 amino acids, which contains tyrosine phosphorylation sites, plays a role in activation of phosphatidylinositol 3-kinase'' and the Raslmitogen-activated protein (MAP) kinase pathway.'' However, this region may not play a role in growth signaling, because truncated mutant EpoRs possess a normal mitogenic function13 or even show an increased activity in a certain cell linei4 or in vivo.15 The latter effect has been hypothesized to be due to the association of hematopoietic cell phosphatase (HCP) with the tyrosine phosphorylated form of the receptor (Yi et all6 and Yi et al, submitted). On the other hand, the membrane proximal region, which shows a limited homology with the other members of cytokine receptor superfamily, was found to be critical for growth signaling from the EpoR.I3." It was thus hypothesized that Jak2 interacts with the membrane proximal region of the EpoR and mediates growth signaling from the EpoR through tyrosine phosphorylation of cellular substrates. However, the substrates of tyrosine phosphorylation and the pathways of signal transduction that are crucial for growth signaling remain to be known.
The receptor for erythropoietin (Epo) belongs to the cytokine receptor family and lacks a tyrosine kinase domain. However, it has been hypothesized that a tyrosine kinase, JakZ, associates with the membrane proximal cytoplasmic region of Epo receptor (EpoR) and mediates the growth signaling from the receptor through tyrosine phosphorylation of cellular substrates. To explore the growth signaling pathways from the EpoR, we analyzed substrates of tyrosine phosphorylation induced by Epo stimulation in cells expressing various mutant EpoRs. The vav proto-oncogene product was found t o be tyrosine phosphorylated after Epo stimulation in cells expressing the wild-type EpoR or a truncated receptor, H mutant, that retains the growth signaling function. In these cells, Epo also induced the expression of a serinelthreonine kinase, Pim-l. However, Epo stimulation E RYTHROPOIETIN (Epo) is a hematopoietic growth factor that regulates the proliferation and differentiation of erythroid progenitor cells.'.' The receptor for Epo ( E~O R )~.~ belongs to the cytokine receptor superfamily, which includes receptors for most of the hematopoietic growth factor^.^.' The receptors of this superfamily are characterized by four conserved cysteine residues and a TrpSer-X-Trp-Ser (WSXWS) motif in the extracellular domain. Although the intracellular domain of the cytokine receptors lacks a tyrosine kinase domain, activation of these receptors induces tyrosine phosphorylation of cellular Using cell lines expressing various mutant EpoRs, we previously showed that a membrane proximal cytoplasmic region of the EpoR plays a crucial role in interaction with and activation of a tyrosine kinase, Jak2.9,'0 We also showed that the carboxyl-terminal region of 108 amino acids, which contains tyrosine phosphorylation sites, plays a role in activation of phosphatidylinositol 3-kinase'' and the Raslmitogen-activated protein (MAP) kinase pathway.'' However, this region may not play a role in growth signaling, because truncated mutant EpoRs possess a normal mitogenic function13 or even show an increased activity in a certain cell linei4 or in vivo.15 The latter effect has been hypothesized to be due to the association of hematopoietic cell phosphatase (HCP) with the tyrosine phosphorylated form of the receptor (Yi et all6 and Yi et al, submitted). On the other hand, the membrane proximal region, which shows a limited homology with the other members of cytokine receptor superfamily, was found to be critical for growth signaling from the EpoR.I3." It was thus hypothesized that Jak2 interacts with the membrane proximal region of the EpoR and mediates growth signaling from the EpoR through tyrosine phosphorylation of cellular substrates. However, the substrates of tyrosine phosphorylation and the pathways of signal transduction that are crucial for growth signaling remain to be known.
In the present studies, we show that Epo induces tyrosine phosphorylation of Vav and expression of Pim-l, which are dependent on the membrane proximal cytoplasmic region of the EpoR. We further show that Jak2 is constitutively acti- did not have any effect on Vav or Pim-l in cells expressing a mutant EpoR, PM4 mutant, inactivated by a point mutation, Trp282 t o Arg, in the membrane proximal region, which abrogates the interaction with Jak2. On the other hand, both tyrosine phosphorylation of Vav and expression of Pim-l were observed constitutively in cells expressing a mutant EpoR that is constitutively activated by a point mutation, Arg129 t o Cys, in the extracellular domain. JaW was also constitutively tyrosine phosphorylated and activated in cells expressing this mutant, which confirms the crucial role of Jak2 in growth signaling from the EpoR. Taken together, these observations suggest that the tyrosine phosphorylation of Vav and the expression of Pim-l may play important roles in growth signaling from the EpoR. 0 1994 by The American Society of Hematology.
vated in cells expressing a previously described mutant EpoR" that is activated by a point mutation, R129C. In these cells, both tyrosine phosphorylation of Vav and expression of Pim-l were also constitutively observed.
MATERIALS AND METHODS

Cells and reagents.
A clone of interleukin-3 (IL-3)-dependent 32D cell line and 32D clones expressing the wild-type or H-and PM4 mutant EpoRs were previously described." IL-3-dependent DA3 cells expressing the wild-type or a constitutively activated mutant EpoR were also previously described.l*~" These cells were maintained in RPM1 1640 medium supplemented with 10% fetal calf serum and 10% WEHI-3 conditioned medium as a source of Rabbit polyclonal antisera against the cytoplasmic portion of recombinant murine EpoRl' or against a synthetic peptide from Jak2" have been described. Antiphosphotyrosine monoclonal antibody (4G10) and rabbit antisera against Vav and Pim-l were purchased from Upstate Biotechnology, Inc (Lake Placid, NY). Recombinant human Epo was kindly provided by Chugai Pharmaceutical CO Ltd (Tokyo, Japan).
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Irnn~~tno~~recipitation and antiphosphotyrosine irnrnunuhlotting. For stimulation with Epo or IL-3, cells were cultured for 12 hours in RPM1 medium without IL-3. The cells were then left unstimulated as a negative control or stimulated with a saturating concentration of Epo or IL-3 at 37°C for 10 minutes. The cells were lysed in a lysis buffer containing 1% Triton X-100, 20 mmol/L Tris-HCI (pH 7.5), 150 mmol/L NaC1, 1 mmol/L EDTA, 100 pmol/L sodium orthovanadate, I mmol/L phenylmethylsulfonyl fluoride, and 10 pg/ mL each of aprotinin and leupeptin.
For immunoprecipitation, cell lysates were incubated with a relevant antibody and protein A-Sepharose beads for 4 hours at 4°C. The immunoprecipitates were resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE), transferred to polyvinylidene difluoride membranes, probed with the 4GI0 antiphosphotyrosine antibody, and developed by the enhanced chemiluminescence (ECL) system (Amersham Corp, Arlington Heights, IL). Aliquots of the cell lysates were also subjected to immunoblotting after directly mixed with equal volumes of 2 x Laemmli's sample buffer and heated at I0O"C for 5 minutes. For reprobing with antiVav, the membranes were treated at 50°C for 30 minutes with stripping buffer containing 100 mmol/L 2-mercaptoethanol, 2% SDS, and 62.5 mmol/L Tris-HCI (pH 6.7) before incubation with antiVav.
In vitro kinase assays. Immunoprecipitates with anti-Jak2 antibody were prepared as described above and subjected to in vitro kinase assays as described previously." In brief, immunoprecipitates were incubated for 30 minutes at room temperature with kinase buffer (I0 mmol/L HEPES, pH 7.4, 50 mmol/L NaCI. 5 mmol/ L MgClz, 5 mmol/L MnCl?, 100 pmol/L sodium orthovanadate) containing 250 pCi/mL [y'*P] ATP. The proteins were resolved by SDS-PAGE and subjected to autoradiography.
lrnrnunohlot analysis ojfirn-l expression. To examine the Pim-I expression, cells were washed out of IL-3 for 12 hours and incubated in RPMI medium without growth factor or in RPMI medium supplemented with Epo or IL-3 for 4 hours at 37°C. After the incubation, the cells were directly lysed with I X Laemli's SDS sample buffer and the lysates, equivalent from 5 X 10' cells, were subjected to 12% SDS-PAGE followed by immunoblotting with anti-Pim-l.
RESULTS
Epo or IL-3 induces tyrosine phosphorylation of Vav in IL-3-dependent cells expressing the transfected EpoR.
To examine substrates of tyrosine phosphorylation induced by stimulation with Epo or IL-3, an IL-3-dependent 32D cell line, 32DEpoR-Wt, expressing the transfected wild-type murine EpoR, was stimulated with Epo or IL-3 and the total cell lysates or anti-Vav immunoprecipitates were examined for tyrosine-phosphorylated proteins by antiphosphotyrosine immunoblotting. As shown in Fig 1 , both Epo and IL-3 induced tyrosine phosphorylation of Jak2 (p130) and Shc (p52 and p49), whereas Epo specifically induced tyrosine phosphorylation of the EpoR (p72), in accordance with our previous studies.'"."." Unidentified major substrates of 92 kD and 70 kD (p92 and p70, respectively) were also observed after Epo or IL-3 stimulation, as previously described.17 In addition, antiphosphotyrosine blotting of the lysates from Epo-or IL-3-stimulated cells showed a broad band of tyrosine-phosphorylated protein(s) just above p92. Antiphosphotyrosine blotting of the anti-Vav immunoprecipitates showed that Epo and IL-3 comparably induce tyrosine phosphorylation of Vav. The tyrosine-phosphorylated Vav appeared as a 97-kD protein and should be contained in the broad band observed in the total cell lysates.
Epo-induced tyrosine phosphorylation of Vav wxs then examined in 32D clones expressing mutant EpoRs previously described."-" 32DEpoR-H cells express the truncated H-mutant that lacks the carboxyl-terminal 108 amino acids, including tyrosine phosphorylation sites. However, this mutant retains the ability to couple with the Jak2 kinase to transduce a mitogenic signal."."' 32D/EpoR-PM4 cells express the PM4 mutant, which has a mutation, Trp"' to Arg (W282R), in the membrane proximal cytoplasmic region showing a homology with other cytokine receptors." This mutation was shown to abolish the ability of EpoR to couple with Jak2."' These clones were stimulated with Epo or IL-3 and the tyrosine phosphorylation of Vav was examined by antiphosphotyrosine blotting of anti-Vav immunoprecipitates. Figure 2 shows that Epo induces the tyrosine phosphorylation of Vav comparably with 1L-3 stimulation in 32D/ EpoR-H, whereas Epo failed to induce any detectable tyrosine phosphorylation of Vav in 32D/EpoR-PM4. Therefore, the carboxyl-terminal 108 amino acid region of EpoR was not required for induction of the tyrosine phosphorylation of Vav, whereas the membrane-proximal region required for coupling with Jak2 was also crucial for the Vav phosphorylation.
A constitutively activated EpoR mutant is associated with constitutive activation of Jak2 and tyrosine phosphorylution of Vuv. A single point mutation, replacing Arg"" with Cys, has been shown to activate the receptor, independent of Epo binding." To explore the mechanisms of growth signaling from the activated mutant, we examined the status of Jak2 and Vav in a factor-independent clone, DA3/EpoR-R129C, obtained by transfecting the R129C mutant into an 1L-3-dependent cell line, DA3.I2 When Jak2 was immunoprecipitated from DA3/EpoR-R129C, in vitro kinase activity of Jak2 was detected in cells grown in the absence of growth factors (Fig 3) . In contrast, no significant Jak2 in vitro kinase activity was detected in cells expressing the wild-type receptor, DA3/EpoR-Wt, when removed from growth factors, in accordance with our previous observation." Stimulation of DAYEpoR-Rl29C cells with Epo resulted in a twofold to threefold increase in in vitro kinase activity. These results show that the constitutively activated R129C mutant causes ligand-independent activation of Jak2, which agrees with the hypothesis that Jak2 plays a crucial role in the EpoR-mediated growth signaling.
The status of tyrosine phosphorylation of Jak2, EpoR, and Vav in cells expressing the constitutively activated EpoR was then examined by antiphosphotyrosine blotting of immunoprecipitates obtained with relevant antibodies.
As
shown in Fig 4A, Jak2 was constitutively tyrosine phosphorylated in DA3/EpoR-R129C, whereas tyrosine phosphorylation of the mutant receptor itself was dependent on Epo stimulation. In DA3EpoR-Rl29C cells, the tyrosine phosphorylation of Vav was observed without stimulation with growth factors and thus correlated with the activation of Jak2 (Fig 4B) .
Induction 
Figure S (left panel) shows that
Epo as well as IL-3 induced expression of the 33-kD Pim-l kinase in 32DEpoR. Epoinduced expression of Pim-l was also examined in cells expressing the various mutant EpoRs. The truncated H mutant retained the ability to induce the Pim-l expression, whereas the PM4 mutant with the inactivating mutation in the membrane proximal region was without this function (Fig S, left panel) . In cells expressing the constitutively activated R129C mutant, Pim-l was expressed constitutively. The abilities of these mutant EpoRs to induce the Pim-l expression thus correlated with their abilities to activate Jak2 and to induce proliferation of cells.
DISCUSSION
The present studies showed that Epo stimulation induces the tyrosine phosphorylation of Vav and the expression of Pim-l. Studies using clones expressing mutant EpoRs showed that the membrane proximal cytoplasmic region of the EpoR, previously shown to be crucial for activation of Jak2," is required for induction of both tyrosine phosphorylation of Vav and expression of Pim-I , whereas the carboxylterminal 108 amino acid region is not required. Furthermore, Jak2 was shown to be constitutively activated in cells expressing the constitutively activated R129C mutant EpoR, in which both tyrosine phosphorylation of Vav and expression of Pim-l were also constitutive. The effects of Epo on Vav and Pim-l thus correlate with activation of Jak2 and induction of proliferation by these mutant EpoRs, which suggest that Vav and Pim-l may play important roles in growth signaling from the EpoR.
Recent studies have shown that the vov proto-oncogene product," selectively expressed in hematopoietic cells, is rapidly and transiently tyrosine phosphorylated in response to stimulation of diverse hematopoietic cell receptors, including the T-cell the IgM receptor,:" the c-kit receptor," the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor," and the IL-3 receptor." Sharing homology with guanine nucleotide releasing factors (GNRFs) that activate Ras-related small guanosine triphosphate (GTP)-binding proteins,'x Vav was shown to possess GNRF activity that increased after the T-cell receptor-CD3 triggering in T cells in parallel with its tyrosine phosphorylation.'" Furthermore, vav-transfected fibroblasts displayed constitutive activation of Ras and MAP kinases,3" known downstream intermediates in Ras-dependent signaling pathways. These observations suggest that Vav may play a role in activation of the Ras signaling pathways by hematopoietic cell receptors.
Previous studies showed that Epo also activates Ras,",'2 and we recently found that Epo stimulates activation of the MAP kinases.'' The tyrosine phosphorylation of Vav induced by Epo stimulation may thus play a role in activation of the Ras signaling pathways by the activated EpoR. However, inconsistent with this possibility, the tyrosine phosphorylation of Vav in cells expressing various mutant EpoRs shown in the present studies failed to correlate with activation of the MAP kinases, which required the carboxyl-terminal region of the EpoR and correlated with tyrosine phosphorylation of Shc and its association with Grb2." Vav may thus play a role in signaling pathways other than the Rad MAP kinase pathways. It should be noted in this regard that Vav has several putative motifs seen in transcription factors" as well as one Src homology 2 domain and two Src homology 3 which are shared by many signaling adapter molecules.33
The pim-l gene was originally identified as a common site for retroviral insertion in T-cell lymphomas in mice." Subsequent studies showed that the pim-l gene is also involved in the generation of B-cell lymphomas" and erythroleukemias.?' The product of the pim-l gene is a cytoplasmic serinekhreonine kinase," expression of which is largely restricted to hematopoietic cells and is highly inducible by hematopoietic growth factors, including IL-2, IL-3, and GMFurthermore, bone marrow-derived mast cells from Pim-1 -deficient mice showed an impaired response to IL-3 in vitro.** These observations suggest that Pim-l may play a role in growth control of hematopoietic cells. In line with this hypothesis, the present studies showed that Epo also induces the expression of Pim-l, which correlated with the proliferation signal transduced from various mutant EpoRs. A possible involvement of Pim-l in erythropoiesis in vivo was also suggested by a previous study showing a correlation between the Pim-1 expression and the erythrocyte mean cell volume in Pim-l-deficient or Ep-pim-l transgenic mice:" Interestingly, a recent study on Ep-pim-I transgenic mice suggested that Pim-l may act as an inhibitor of apoptosis:'
Because one of the important functions of Epo is to prevent apoptosis of erythroid progenitor cells:* it will be of interest to study a possible involvement of Pim-1 in EpoR-mediated prevention of apoptosis.
In cells expressing the constitutively activated mutant EpoR, Jak2 was constitutively tyrosine phosphorylated and displayed the autophosphorylation activity in vitro without Epo stimulation. This finding is consistent with the hypothesis that Jak2 is the kinase that mediates the growth signaling from the EpoR. In addition, these results suggest that the constitutively activated EpoR, which may be activated by dimerization:' activates the same growth signaling pathway with the ligand-activated EpoR. It will be important to determine whether the activation of EpoR by the gp55 glycoprotein of the Friend spleen focus-forming virus," which is involved in the initial stage of Friend erythroleukemia, is also associated with activation of Jak2.
The tyrosine phosphorylation of the R129C mutant, which constitutively activates Jak2, was dependent on Epo stimulation. This finding is inconsistent with our previous studies, which suggested that the EpoR is a substrate for Jak2.'0.4s However, it is possible that the tyrosine-phosphorylated EpoR may be susceptible to dephosphorylation by HCP, which binds the tyrosine phosphorylated carboxyl-terminal region of the EpoR (Yi et al, submitted) or other protein tyrosine phosphatases. Then, further activation of Jak2 by CSF.*l.X8.XY Epo stimulation may be required to cause easily detectable tyrosine phosphorylation of the R129C mutant. In contrast, there was very little enhancement of the phosphorylation of Vav after Epo stimulation in DA3EpoR-RI29C. It is thus suggested that the level of Jak2 kinase activity constitutively activated by the R129C mutant may be sufficient for causing, directly or indirectly, significant tyrosine phosphorylation of Vav. It is also implied that the tyrosine phosphorylated Vav may not be susceptible to dephosphorylation by protein tyrosine phosphatases.
The present studies showed that the membrane proximal cytoplasmic region of EpoR is required for induction of the expression of Pim-1. Because the membrane proximal region of EpoR is also required for association with and activation of Jak2, activation of Jak2 may be required for induction of Pim-l. Consistent with this possibility, recent studies using mutant pc chains of the GM-CSF receptor showed that the membrane proximal region of the pc chain is required for both Jak2 activation and induction of the Pim-l expression.4s.4' Similar to the results of our previous studies on EpoR mutants, the membrane distal region of the pc chain was dispensable for growth signaling but was required for the tyrosine phosphorylation of Shc and activation of the Ras/MAP kinase pathways by the GM-CSF Thus, tyrosine kinases other than Jak2 may be involved in activation of these pathways by the cytokine receptors. On the other hand, the tyrosine phosphorylation of Vav was apparently dependent on the membrane proximal region of the EpoR, thus suggesting that Jak2 may be directly responsible for its phosphorylation. Alternatively, activated Jak2 may activate a tyrosine kinase that may phosphorylate Vav. Irrespective, further studies toward identification of cellular substrates of Jak2 are required to elucidate the molecular and biochemical mechanisms of EpoR-mediated signaling. 
